Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

RICI HEALTH (1526.HK)

Compare
1.170
-0.010
(-0.85%)
At close: April 3 at 3:48:00 PM GMT+8
Loading Chart for 1526.HK
  • Previous Close 1.180
  • Open 1.200
  • Bid 1.130 x --
  • Ask 1.180 x --
  • Day's Range 1.170 - 1.200
  • 52 Week Range 0.960 - 1.450
  • Volume 5,000
  • Avg. Volume 76,836
  • Market Cap (intraday) 1.861B
  • Beta (5Y Monthly) 0.72
  • PE Ratio (TTM) 5.57
  • EPS (TTM) 0.210
  • Earnings Date Mar 28, 2025
  • Forward Dividend & Yield 0.09 (7.69%)
  • Ex-Dividend Date Sep 10, 2024
  • 1y Target Est --

Rici Healthcare Holdings Limited, an investment holding company, operates general hospitals, medical examination centers, medical laboratories, and clinics in the People's Republic of China. It also offers health counseling, maternity and child nursing, diagnosis, and examination services. In addition, the company sells medical equipment. Rici Healthcare Holdings Limited was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

www.rich-healthcare.com

8,908

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1526.HK

View More

Performance Overview: 1526.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1526.HK
6.40%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

1526.HK
11.87%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

1526.HK
48.96%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

1526.HK
52.27%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 1526.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1526.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    1.86B

  • Enterprise Value

    3.71B

  • Trailing P/E

    5.47

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.59

  • Price/Book (mrq)

    1.43

  • Enterprise Value/Revenue

    1.18

  • Enterprise Value/EBITDA

    5.59

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.17%

  • Return on Assets (ttm)

    8.24%

  • Return on Equity (ttm)

    28.50%

  • Revenue (ttm)

    2.92B

  • Net Income Avi to Common (ttm)

    297.32M

  • Diluted EPS (ttm)

    0.210

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.12B

  • Total Debt/Equity (mrq)

    167.28%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1526.HK

View More

Company Insights: 1526.HK

Research Reports: 1526.HK

View More

People Also Watch